The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
Open accessAbstract
Glucocorticoids (GCs) are broadly prescribed for numerous pathological conditions because of their anti-inflammatory, antiallergic and immunosuppressive effects, among other actions. Nevertheless, GCs can produce undesired diabetogenic side effects through interactions with the regulation of glucose homeostasis. Under conditions of excess and/or long-term treatment, GCs can induce peripheral insulin resistance (IR) by impairing insulin signalling, which results in reduced glucose disposal and augmented endogenous glucose production. In addition, GCs can promote abdominal obesity, elevate plasma fatty acids and triglycerides, and suppress osteocalcin synthesis in bone tissue. In response to GC-induced peripheral IR and in an attempt to maintain normoglycaemia, pancreatic β-cells undergo several morphofunctional adaptations that result in hyperinsulinaemia. Failure of β-cells to compensate for this situation favours glucose homeostasis disruption, which can result in hyperglycaemia, particularly in susceptible individuals. GC treatment does not only alter pancreatic β-cell function but also affect them by their actions that can lead to hyperglucagonaemia, further contributing to glucose homeostasis imbalance and hyperglycaemia. In addition, the release of other islet hormones, such as somatostatin, amylin and ghrelin, is also affected by GC administration. These undesired GC actions merit further consideration for the design of improved GC therapies without diabetogenic effects. In summary, in this review, we consider the implication of GC treatment on peripheral IR, islet function and glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Endocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Ferron, M., Hinoi, E., Karsenty, G., & Ducy, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711119105 · Cited by 900
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696
Ghrelin Modulates Brain Activity in Areas that Control Appetitive Behavior
Malik, S., McGlone, F., Bedrossian, D., & Dagher, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.007 · Cited by 677
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P. G., Athyros, V. G., Τζιόμαλος, Κ., Karagiannis, A. I., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 625
Genomic and nongenomic effects of glucocorticoids
Stahn, C., & Buttgereit, F. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0898 · Cited by 594
Research works printed but not linked: 18
- 1984, American Journal of Physiology -- Legacy Content, 247, E592
- Brown, 1993, Endocrinology, 132, 2614, 10.1210/en.132.6.2614 · DOI · Paper page
- Hoes, 2010, Clinical and experimental rheumatology, 28, 354
- 1992, American Journal of Physiology -- Legacy Content, 263, E663
- 2014, Endocrinology, 27, 48
- 2011, MODERN RHEUMATOLOGY, 21, 495, 10.3109/s10165-011-0433-8 · DOI
- 1994, JOURNAL OF CLINICAL ENDOCRINOLOGY, 79, 820
- 1994, JOURNAL OF CLINICAL ENDOCRINOLOGY, 78, 1354
- 1993, American Journal of Physiology -- Legacy Content, 265, E446
- 1993, JOURNAL OF CLINICAL ENDOCRINOLOGY, 77, 1180
- 1998, American Journal of Physiology -- Legacy Content, 275, E806
- 1994, Journal of liposome research, 35, 1535
- 2008, NATURE CLINICAL PRACTICE RHEUMATOLOGY, 4, 525
- 1990, American Journal of Physiology -- Legacy Content, 258, E748
- T uber, 1984, International journal of clinical pharmacology, therapy, and toxicology, 22, 48
- 1990, American Journal of Physiology -- Legacy Content, 259, E626
- 1992, PNAS, 89, 35
- 2013, Journal of Molecular Endocrinology, 19, R35
Cited by
Sorted by citations
Items 101–200 of 215
Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
Zhu, K., Zhang, Y., Zhang, J., Zhou, F., Zhang, L., Wang, S., Zhu, Q., Liu, Q., Wang, X., & Zhou, L. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.11.022 · Cited by 13
Molecular mechanism of glucocorticoid-induced hyperglycemia
Sari, D. A., Samodra, G., & Kusuma, I. Y. (2021) · Pharmacy Reports · doi:10.51511/pr.1 · Cited by 12
Human Beta Cell Functional Adaptation and Dysfunction in Insulin Resistance and Its Reversibility
Klemen, M. S., Kopecký, J., Dolenšek, J., & Stožer, A. (2023) · The Nephron journals/Nephron journals · doi:10.1159/000534667 · Cited by 13
Batista, E. K. D. L., de Lima, L. M. A., Gomes, D. A., Crans, D. C., Silva, W. E., Belian, M. F., & Lira, E. C. (2024) · Pharmaceuticals · doi:10.3390/ph17060760 · Cited by 12
Guarnotta, V., Amodei, R., & Giordano, C. S. D. S. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.07.003 · Cited by 11
Liang, M., Xiong, L., Li, A., Zhou, J., Huang, Y., Huang, M.-F., Zhang, X., Shi, H., Su, N., Wei, Y., et al. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02661-6 · Cited by 13
Abordagem e Tratamento da Hiperglicemia Induzida por Glicocorticóides
Paredes, S., & Alves, M. (2016) · Acta Médica Portuguesa · doi:10.20344/amp.7758 · Cited by 12
Glucococorticoid-Induced Death of Pancreatic Beta Cells: An Organized Chaos
Rojas, J., Chávez-Castillo, M., Chávez-Castillo, M., Cabrera, M., Cabrera, M., Bermúdez, V., & Bermúdez, V. (2015) · PubMed · doi:10.6092/1590-8577/2893 · Cited by 12
Mohammed, M. A., Mahmoud, M. O., Awaad, A. S., Gamal, G. M., & Abdelfatah, D. (2019) · Steroids · doi:10.1016/j.steroids.2019.01.004 · Cited by 11
Henquin, J. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154821 · Cited by 13
Han, M., Cao, X., Zhao, C., Yang, L., Yin, N., Shen, P., Zhang, J., Gao, F., Ren, Y., Liang, D., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.544752 · Cited by 10
Karagiannopoulos, A., Westholm, E., Ofori, J. K., Cowan, E., Esguerra, J. L. S., & Eliasson, L. (2023) · iScience · doi:10.1016/j.isci.2023.106555 · Cited by 10
Ghrelin receptor signaling is not required for glucocorticoid-induced obesity in female mice
Silver, Z. A., Abbott-Tate, S., Hyland, L., Sherratt, F., Woodside, B. C., & Abizaid, A. B. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0579 · Cited by 10
Kurni, M., Kaloria, N., Hazarika, A., Jain, K., Gupta, S., & Walia, R. (2023) · Korean Journal of Neurotrauma · doi:10.13004/kjnt.2023.19.e4 · Cited by 9
Cortisol in metabolic syndrome
Mazgelytė, E., & Karčiauskaitė, D. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.06.008 · Cited by 18
The effect of acute and short term glucocorticoid administration on exercise capacity and metabolism
Tacey, A., Parker, L., GARNHAM, A. P., Brennan‐Speranza, T. C., & Levinger, I. (2017) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2016.10.016 · Cited by 9
Kheirbakhsh, R., Haddadi, M., Muhammadnejad, A., Abdollahi, A., Shahi, F., Amanpour‐Gharaei, B., Abrahim-Habibi, A., Barati, T., & Amanpour, S. (2018) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2018-004 · Cited by 9
Bidirectionality of hormone-behavior relationships and satellite-caller dynamics in green treefrogs
Crocker‐Buta, S., & Leary, C. J. (2018) · Behavioral Ecology · doi:10.1093/beheco/ary047 · Cited by 9
Du, X., Xu, W., Shi, J., Guo, K., Guo, C., Zheng, R., Jiang, S., & Chai, J. (2021) · Biomolecules · doi:10.3390/biom11050721 · Cited by 8
Lithium treatment mitigates the diabetogenic effects of chronic cortico-therapy
Delangre, E., Pommier, G., Tolu, S., Uzan, B., Bailbé, D., & Movassat, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114895 · Cited by 9
Badmus, O. O., & Olatunji, L. A. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1479426 · Cited by 8
Zhao, Q., Zhou, J., Pan, Y., Ju, H., Zhū, L., Liu, Y., & Zhang, Y. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01566-w · Cited by 8
Singh, P., Brock, C. O., Volden, P. A., Hernandez, K. M., Skor, M. N., Kocherginsky, M., Park, J. E., Brady, M., & Conzen, S. D. (2015) · Obesity · doi:10.1002/oby.21251 · Cited by 9
Roussel, M., Mathieu, J., & Dalle, S. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0071 · Cited by 8
Serum cortisone and glucocorticoid receptor gene (NR3C1) polymorphism in human dysglycemia
Wei, D., Liu, X., Huo, W., Yu, S., Li, L., Wang, C., & Mao, Z. (2020) · HORMONES · doi:10.1007/s42000-020-00196-9 · Cited by 8
Glucocorticoids and glucolipotoxicity alter the DNA methylome and function of human EndoC-βH1 cells
dos Santos, C., Karagiannopoulos, A., Rafacho, A., Perfilyev, A., Eliasson, L., Ling, C., & Bacos, K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120854 · Cited by 7
Ren, J., Dai, J., Chen, Y., Wang, Z., Sha, R., Mao, J., & Mao, Y. (2024) · Metabolites · doi:10.3390/metabo14040224 · Cited by 7
Garcia, E. L. L., Debensason, D., Capron, L., Flahault, A., & Pommier, J. (2018) · BMC Public Health · doi:10.1186/s12889-018-5384-y · Cited by 7
Diabetic ketoacidosis in acromegaly; a rare complication precipitated by corticosteroid use
Weiss, J., Wood, A. J., Zajac, J. D., Grossmann, M., Andrikopoulos, S., & Ekinci, E. I. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.023 · Cited by 7
Badmus, O. O., Michael, O. S., Rabiu, S., & Olatunji, L. A. (2018) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2018.04.013 · Cited by 7
The effect of serum cortisol on the prediabetes stage under normal and stress state
Jabbar, A. A., & Majeed, M. J. (2020) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/928/5/052019 · Cited by 7
Korol, S., White, M., O’Meara, E., Rouleau, J. L., White‐Guay, B., Dorais, M., Ahmed, A., de Denus, S., & Perreault, S. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-02615-8 · Cited by 7
The progression of secondary diabetes: A review of modeling studies
Yang, B., Li, J., Haller, M. J., Schatz, D. A., & Rong, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1070979 · Cited by 6
“Although the causal relationship between GCs and dysglycemia is affirmative, the impact of GCs on the pancreatic beta-cells remains debatable (21).”
BackgroundOkano, S. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3459246 · Cited by 7
Divyaveer, S. S., Patil, M., Raychaudhary, A., Trivedi, M., Mahajan, C., Sarkar, D., & Pandey, R. P. (2019) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.252902 · Cited by 6
Gulfo, J., Román, J. P. D. S., Ledda, A., Junyent, F., Ramírez, M. J., Gil-Bea, F. J., Esteve, M., & Grasa, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246930 · Cited by 6
Ohira, M., Kawagoe, N., Kameyama, C., Kondou, Y., Igarashi, M., & Ueshiba, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01706-8 · Cited by 9
Tiwari, P., Kumar, P., Srikrishna, S., Siddiqi, N. J., & Sharma, B. (2025) · Toxics · doi:10.3390/toxics13100897 · Cited by 5
Gong, Z., QIN, Y., Wang, Y., Liu, X., Jiang, L., Cui, D., & Zhang, M. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109994 · Cited by 7
Cazzola, M., Hanania, N. A., Page, C. P., Calzetta, L., Matera, M. G., & Rogliani, P. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2514607 · Cited by 5
Dunford, E. C., Mandel, E. R., Mohajeri, S., Haas, T. L., & Riddell, M. C. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00146.2016 · Cited by 5
Kawashima, M., Taguchi, K., Kitada, Y., Yamauchi, M., Ikeda, T., Kajita, K., Murakami, D., Okada, H., Uno, Y., Mori, I., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.043 · Cited by 5
A simple screening score to predict diabetes in cancer patients
Kim, J., Ko, S.-H., Baeg, M. K., & Han, K.-D. (2019) · Medicine · doi:10.1097/md.0000000000018354 · Cited by 5
Kim, Y. J. (2017) · Journal of Acupuncture and Meridian Studies · doi:10.1016/j.jams.2017.05.003 · Cited by 5
Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency
Guarnotta, V., Tomasello, L., & Giordano, C. S. D. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-04904-w · Cited by 4
Diabetes-inducing effects of bronchial asthma
Al‐Beltagi, M., Bediwy, A. S., Saeed, N. K., Bediwy, H. A., & Elbeltagi, R. M. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i1.97954 · Cited by 4
Hormone Response Pathways as Responders to Environmental Contaminants and Their Roles in Disease
Tilley, S. K., & Fry, R. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801564-3.00010-9 · Cited by 4
Mathias, P. C. D. F., Rodrigues, A. M. D., Lisboa, P. C., Miranda, R. A., Malta, A., Ribeiro, T. A., Barella, L. F., Miranda, G. D. S., de Lima, T. A. L., Gomes, R. M., et al. (2024) · Biology · doi:10.3390/biology13121036 · Cited by 3
Tijani, O. K., Moreno-Lopez, M., Louvet, I., Acosta-Montalvo, A., Coddeville, A., Gmyr, V., Kerr-Conte, J., Pattou, F. N., Vantyghem, M., Saponaro, C., et al. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.101676 · Cited by 4
Karino, G., Murakoshi, T., Nakamura, S., Kunikata, T., Yamanouchi, H., & Koshiba, M. (2015) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2015.03.005 · Cited by 3
Metabolic Changes in Children that Received Chemotherapy
Soto-Vega, E. N., Carrillo-Vicente, L. S., Vázquez, J. C., Herrero, M. D. L. C. P. D. C., & Muñoz‐Pérez, M. J. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001401 · Cited by 3
Badmus, O. O., Anoka, N. A., Ologe, M. O., & Olatunji, L. A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103423 · Cited by 3
Diseased human pancreas and liver microphysiological system for preclinical diabetes researchPreprint
Rigal, S., Casas, B., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Müllers, E., Karlsson, F. H., Clausen, M., Hansson, S., Jansson‐Löfmark, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.03.547412 · Cited by 3
Um, Y. H., Han, K., Kim, T., Jeong, J., Hong, S., & Seo, H. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.066 · Cited by 2
Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implications
Matera, M. G., Page, C. P., Calzetta, L., Rogliani, P., & Cazzola, M. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2632668 · Cited by 3
Vorwald, M. E., Krishna, S., Lee, J. H., Roths, M. S., Valentine, R. J., & Selsby, J. T. (2026) · The Journal of Physiology · doi:10.1113/jp289832 · Cited by 2
de Santana, L. B., Lima, T. A. D. S., Costa, A. R., Sandoval, L., de Souza, T. Y., da Mota, L. M. H., & Naves, L. A. (2024) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-024-00394-8 · Cited by 2
Bertin, F., Eps, A. W. V., de Tonnerre, D. J., Kulp, J. C., & Stefanovski, D. (2025) · American Journal of Veterinary Research · doi:10.2460/ajvr.24.12.0373 · Cited by 3
Mathematical Modelling for Glucose Homeostasis and Associated Mechanisms: A State-of-the-Art Review
Lamlili, M. E. N., Boutayeb, W., & Boutayeb, A. (2025) · Industrial and applied mathematics · doi:10.1007/978-981-96-1925-2_2 · Cited by 2
Araújo, J. E. D. S., Macedo, F. N., Oliveira, D. P. M., de Britto, R. M., Quintans, J. D. S. S., Barreto, R. D. S. S., dos Santos, M. R. V., Quintans‐Júnior, L. J., & Barreto, A. S. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020200316 · Cited by 2
Perna‐Barrull, D., Murillo, M., Real, N., Gómez-Muñoz, L., Rodríguez-Fernández, S., Bel, J., Puig‐Domingo, M., & Vives‐Pi, M. (2022) · Journal of Diabetes Research · doi:10.1155/2022/6598600 · Cited by 2
Insulin resistance-driven beta-cell adaptation in mice: Mechanistic characterization and 3D analysisPreprint
Liboz, A., Beaupère, C., Roblot, N., Tinévez, J.-Y., Guilmeau, S., Burnol, A., Gueddouri, D., Prieur, X., Fève, B., Guillemain, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.09.523222 · Cited by 2
Alam, G. M. I., Tanim, S. A., Shrestha, T. E., Raihan, M., & Nur, K. M. (2025) · Lecture notes in networks and systems · doi:10.1007/978-981-96-3358-6_22 · Cited by 1
AlMubayedh, H. O., Almehizia, R., Salam, A., Alghunaim, R., Mohammed, O., Alrbiaan, A., & Al‐Qadheeb, N. S. (2025) · Critical Care Explorations · doi:10.1097/cce.0000000000001290 · Cited by 1
Beta-cell adaptation unveiled: The role of myokines in insulin-resistant mice
Liboz, A., Beaupère, C., Roblot, N., Rousseau, E., Tinévez, J.-Y., Guilmeau, S., Burnol, A., Gueddouri, D., Prieur, X., Annicotte, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116283 · Cited by 2
Eldakhakhny, B. M., Ghoneim, F. M., Almoghrabi, Y. M., Ajabnoor, G., Alandejani, F., El‐khair, S. M. A., Elsamanoudy, S. A., Shamrani, T., Siddiqui, M. A., & Elsamanoudy, A. Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1704597 · Cited by 1
Lipodystrophy look-alikes: navigating diagnostic overlap with endocrine diseases
Ceccarini, G., Gilio, D., Magno, S., Palladino, L., & Santini, F. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag067 · Cited by 2
Diabetes esteroidea en niños prepúberes: un diagnóstico por confirmar
García, E. G., & Ojeda, F. D. L. C. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.03.003 · Cited by 1
Kocatürk, E., Kar, E., Kiraz, Z. K., & Alataş, İ. Ö. (2021) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.20591 · Cited by 1
Antevska, A., Long, C. C., Dupuy, S. D., Collier, J. J., Karlstad, M. D., & Do, T. D. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00668 · Cited by 2
G6PC1 and G6PC2 influence G6P flux but not HSD11B1 activity
Hawes, E. M., Boortz, K. A., Oeser, J. K., O’Rourke, M. L., & O’Brien, R. M. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0070 · Cited by 1
Wang, Q., Bai, W., Li, C., Sun, S., Zhang, X., & Zhao, A. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104395 · Cited by 1
Abdelwhab, S. M., Shehata, O. Z., Magd, Y. A. E., & Kamal, A. (2018) · Egyptian Rheumatology and Rehabilitation · doi:10.4103/err.err_42_17 · Cited by 1
Basic and clinical aspects of glucocorticoid action in bone
Zhou, H., Cooper, M. S., & Seibel, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00039-7 · Cited by 1
1. Obesity Secondary to Endocrinological Disorders
Yanase, T., Nomiyama, T., & Tanabe, M. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.690
Corticotrophin deficiency in end-stage renal failure led to recurrent hypoglycemia: A case report
Wagner, B., & Peter, H. (2015) · Medical Case Studies · doi:10.5897/mcs2015.0109
Avaliação da sensibilidade à insulina em pacientes com lúpus eritematoso sistêmico
Miyake, C. N. H. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-08092016-100644
Steroid diabetes before puberty: A diagnosis to confirm
García, E. G., & Ojeda, F. D. L. C. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.03.016
Keyany, A., Nielen, J. T. H., Souverein, P. C., de Vries, F., & van den Bemt, B. J. F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.010
Scott, K. L. (2018) · SUNScholar (Stellenbosch University)
Giordano, R. (2018) · Clinical Endocrinology · doi:10.1111/cen.13748
Prediction and Utility of a clinical fracture risk score in administrative claims
Overman, R. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/h09q-3v83
Management and Treatment of Glucocorticoid-induced Diabetes Mellitus
Marques, B., Bastos, M., Martins, R., Rodrigues, F., & Carrilho, F. (2019) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ar180034
Bolina, V. M. G., Mendonça, T. S., Pereira, M. L., Domingueti, C. P., Rodrigues, J. P. V., dos Reis, T. M., & Baldoni, A. O. (2020) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2019.104.0343
Herbs and Spices as Natural Medicine for Treatment of Metabolic Disorders
Itrat, N. (2020) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-45923-9_27
Exploring the Function of G6PC2 in Pancreatic Islet Beta Cells
Boortz, K. A. (2016)
Шупрович, А. (2020) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2020-3-59
Treatment of hepatitis C virus infection and associated glomerular disease
Tudorovici, D.-G., & Penescu, M. N. (2020) · Romanian Medical Journal · doi:10.37897/rmj.2020.3.1
Chemical Isotope Labeling LC-MS for Tissue, Serum and Urine Metabolomics
Wang, X. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3gb1xz8m
Guarnotta, V., Tomasello, L., & Giordano, C. S. D. S. (2021) · Research Square · doi:10.21203/rs.3.rs-965895/v1
The current state of diabetes treatment
Danquah, M. K., & Jeevanandam, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85396-5.00007-5
Schlienger, J.-L. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00025-7
Minimising Cardiometabolic Risk Factors in Patients with Hypopituitarism
Armeni, E., & Grossman, A. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_20
Glucocorticoid action in osteoblasts and systemic energy metabolism
Zhou, H., & Seibel, M. J. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100432
Asthma and Cardiovascular Diseases: A Mendelian Randomization StudyPreprint
Zhao, Y., & Xu, F. (2023) · Research Square · doi:10.21203/rs.3.rs-3739165/v1
Liboz, A., Beaupère, C., Roblot, N., Tinévez, J.-Y., Guilmeau, S., Burnol, A., Ghueddouri, D., Prieur, X., Fève, B., Guillemain, G., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4789208 · Cited by 1
Metadata
- Authors
- Rafacho, A., Ortsäter, H., Nadal, A., & Quesada, I.
- Affiliations
- Universitat de Miguel Hernández d'Elx (ES)
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2014-09-30
- Volume
- 223
- Issue
- 3
- Pages
- R49-R62
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2170071103
- Cited by
- 216
- References
- 124
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 21 · 2023: 14 · 2022: 19 · 2021: 18 · 2020: 18 · 2019: 27 · 2018: 27 · 2017: 16 · 2016: 22 · 2015: 15 · 2014: 1
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- Funders
- European Foundation for the Study of Diabetes
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (471397/2011-3)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoids, diabetogenic effect, glucose homeostasis, insulin resistance, beta-cell function, hyperinsulinemia, hyperglycemia, hyperglucagonaemia, islet hormones, somatostatin, amylin, ghrelin, osteocalcin, abdominal obesity, insulin signaling
- MeSH terms
- Animals, Blood Glucose, Diabetes Mellitus, Type 2, Glucocorticoids, Glucose, Homeostasis, Humans, Insulin Resistance, Islets of Langerhans, Models, Biological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review